title: Induction of labour with an unfavourable cervix.
abstract: Labour induction is undertaken when the advantages for the mother and/or the baby are considered to outweigh the disadvantages. When the uterine cervix is unfavourable, oxytocin, with or without amniotomy, is frequently ineffective. Vaginal prostaglandin E(2) is most commonly used if it is affordable. Evidence regarding many alternative methods is discussed in this chapter. Of particular interest are misoprostol and extra-amniotic saline infusion.Misoprostol, an orally active prostaglandin E(1) analogue, has been used widely by the vaginal and oral routes for labour induction at or near term. Several recent trials have confirmed that it is highly effective. Overall Caesarean section rates appear to be reduced, despite a relative increase in Caesarean sections for fetal heart rate abnormalities. Concern remains regarding increased rates of uterine hyperstimulation and meconium-stained amniotic fluid, although data on perinatal outcome have been reassuring. Postpartum haemorrhage may be increased following labour induction with misoprostol, and isolated reports of uterine rupture, with or without previous Caesarean section, have appeared. Using small dosages appears to reduce adverse outcomes. Very large trials are needed to evaluate rare adverse outcomes.Extra-amniotic saline infusion is an effective method which appears to reduce the risk of uterine hyperstimulation that occurs with the use of exogenous uterotonics.
authors.affiliation: East London Hospital Complex, South Africa Effective Care Research Unit, Frere Maternity Hospital, University of the Witwatersrand, East London. gjh@global.co.za
authors.forename: G
authors.initials: G
authors.lastname: Justus Hofmeyr
mesh_terms: D002404:Catheterization; D020070:Cervical Ripening; D002584:Cervix Uteri / Q000000981:diagnostic imaging; D015232:Dinoprostone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D016595:Misoprostol / Q000627:therapeutic use*; D010120:Oxytocics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D014463:Ultrasonography
chemical_list: D010120:Oxytocics; D016595:Misoprostol; D015232:Dinoprostone